The DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index.
Optimal antibiotic use in the intensive care unit
Open accessAbstract
BACKGROUND: Antibiotic resistance has emerged as one of the most important factors influencing the outcomes of patients with life-threatening infections in the ICU. The increasing prevalence of antibiotic-resistant infections globally highlights the importance of this issue for all intensivists. MAIN BODY: Antibiotic utilization in the ICU should be optimized to ensure that timely appropriate treatment is administered in a way that minimizes the subsequent emergence of antibiotic resistance. Antibiotic strategies have been developed to assist clinicians in achieving this important balance. Familiarity with local ICU pathogens and their antibiotic susceptibilities is at the forefront of optimizing ICU antibiotic practices. Moreover, timely antibiotic administration along with pharmacokinetic/pharmacodynamic (PK/PD) optimization, including ideal dosing and infusion duration, should be key components of all ICU antibiotic strategies. Microbiologic testing to include conventional pathogen identification and susceptibility testing as well as use of microbiologic rapid diagnostic tests can confirm the antibiotic regimen that is required to treat the causative pathogens while allowing de-escalation to occur if possible. Similarly, biomarkers such as procalcitonin can aid with avoiding unnecessary antibiotic use in the ICU and shortening their overall duration. ICUs should routinely employ formal programs for reviewing and optimizing antibiotic practices. These programs can include directed input from pharmacists and microbiologists during ICU rounds, the use of specialized order sets focusing on duration of treatment with stop as well as dosing optimization guidance, use of computerized decision support tools, incorporated protocols for the prevention of nosocomial infections, and the appropriate use of antibiotic prophylaxis regimens to include selective digestive decontamination (SDD). Tracking antibiotic practices in the ICU, as well as changing patterns of pathogens and antibiotic susceptibilities, mandate regular modification and updating of these practices over time. Antibiotic combination regimens can also be employed in some circumstances to increase the likelihood of treatment success with an appropriate initial regimen while also reducing the propensity for resistance emergence. Additionally artificial intelligence/machine learning (AI/ML) methods will increasingly serve to enhance antibiotic decision making in the future. CONCLUSION: Antibiotic optimization strategies in the ICU should routinely be employed by a multi-specialty group including intensivists, microbiologists, pharmacists, infectious disease specialists, and infection control practitioners. Regular review and updating of ICU antibiotic practices will help to safeguard their long-term use to optimize patient outcomes while minimizing resistance emergence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“ICU studies and expert statements support narrowing therapy when the clinical and microbiological evidence permits, while cautioning against indiscriminate discontinuation in unstable patients (19–21).”
From Day-4 antipseudomonal and anti-MRSA de-escalation was not associated with higher mortality in critically ill patients with sepsis (2026) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“Kumar et al described that each hour of delay in starting antibiotics led to a 7.6% decrease in survival for patients with septic shock [15].”
InfluentialSurviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082 · cited 2×
“ADE should take place as soon as possible to minimize the potential adverse effects of broad-spectrum antibiotics [69, 77].”
InfluentialKalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., Napolitano, L. M., O'Grady, N. P., Bartlett, J. G., Carratalà, J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw353 · Cited by 3,892
Naghavi, M., Vollset, S. E., Ikuta, K. S., Swetschinski, L. R., Gray, A. P., Wool, E. E., Robles Aguilar, G., Mestrovic, T., Smith, G., Han, C., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01867-1 · Cited by 3,791
Metlay, J. P., Waterer, G. W., Long, A. C., Anzueto, A., Brozek, J., Crothers, K., Cooley, L. A., Dean, N. C., Fine, M. J., Flanders, S. A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1581st · Cited by 3,657
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908 · cited 1×
“For beta-lactams, the PK/PD parameter associated with bacterial killing or efficacy is the time above organism MIC, but the target varies by infusion strategy and β-lactam class [52–54].”
Stevens, D. L., Bisno, A. L., Chambers, H. F., Dellinger, E. P., Goldstein, E. J. C., Gorbach, S. L., Hirschmann, J. V., Kaplan, S. L., Montoya, J. G., & Wade, J. C. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu296 · Cited by 2,780
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225
Ferrer, R., Martin-Loeches, I., Phillips, G., Osborn, T. M., Townsend, S., Dellinger, R. P., Artigas, A., Schorr, C., & Levy, M. M. (2014) · Critical Care Medicine · doi:10.1097/ccm.0000000000000330 · Cited by 1,480
Cited by
Zhang, Y., Liao, G., Song, J., Liao, Y., & Zhang, L. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1924203
Metadata
- Authors
- Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H.
- Affiliations
- University of Health Sciences and Pharmacy (US)
- Washington University in St. Louis (US)
- Barnes-Jewish Hospital (US)
- Corresponding author
- Kollef, Marin H.
- Venue
- Critical Care
- Published
- 2025-10-14
- Volume
- 29
- Issue
- 1
- Pages
- 434-434
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC12522909
- OpenAlex
- W4415156452
- Cited by
- 11
- References
- 157
- Citations by year
- 2026: 11
- FWCI
- 0.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Critical Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Digital Commons@Becker (Washington University School of Medicine) (submittedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- antibiotic stewardship, intensive care unit, antibiotic resistance, antibiotic de-escalation, procalcitonin, antibiotic dosing, decision support system, selective decontamination of the digestive tract, antibiotic prophylaxis, nosocomial infection prevention, antimicrobial susceptibility
- MeSH terms
- Anti-Bacterial Agents, Drug Utilization, Humans, Intensive Care Units
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Optimal antibiotic use in the intensive care unit. https://app.cochat.ai/papers/10.1186/s13054-025-05653-8
- The paper
- Micek, S. T., Vazquez Guillamet, M. C., Reynolds, D., Matuszak, S., Kolodziej, L., & Kollef, M. H. (2025). Optimal antibiotic use in the intensive care unit. Critical Care. https://doi.org/10.1186/s13054-025-05653-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.